Legal Opinion
Takeda Pharmaceutical Co. v. Teva Pharmaceuticals USA Inc.
District Court, D. Delaware
Decided March 31, 2008No. Civ. 06-033-SLRPublishedCited by 2 opinions
1Opinion of the Court
OPINION
SUE L. ROBINSON, District Judge.
I. INTRODUCTION
This action arises out of the filing of an Abbreviated New Drug Application (“ANDA”) 1 by Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd. (collectively, “Teva”) to market a generic version of the antibacterial drug PREVACID® proprietary to Takeda Pharmaceutical Company, Ltd. (“Takeda”) and exclusive licensee TAP Pharmaceutical Products Inc. (“TAP”) (collectively, “Take-da”). The active ingredient in PREVA- CID ® is lansoprazole, which is protected by, inter alia, U.S. Patent Nos. 4,628,098 (“the '098 patent”) and…
2Cases cited29 opinions
- Graham v. John Deere Co. of Kansas CitySupreme Court of the United States · 1966
- Edward H. Phillips v. Awh Corporation, Hopeman Brothers, Inc., and Lofton Corporation, Defendants-CrossCourt of Appeals for the Federal Circuit · 2006
- KSR International Co. v. Teleflex Inc.Supreme Court of the United States · 2007
- Precision Instrument Manufacturing Co. v. Automotive Maintenance MacHinery Co.Supreme Court of the United States · 1945
- Teleflex, Inc. v. Ficosa North America Corp., Fico Cables, S.A., and Ficosa North America S.A. De C.V.Court of Appeals for the Federal Circuit · 2002
24 more not listed; retrieve them via the Exa API.
3Cited by2 opinions
- Otsuka Pharmaceutical Co. v. Torrent Pharmaceuticals Ltd.District Court, D. New Jersey · 2015
- Mitsubishi Chemical Corp. v. Barr Laboratories, Inc.District Court, S.D. New York · 2010